Pharmacoeconomic Assessment of Nintedanib For The Treatment of Idiopathic Pulmonary Fibrosis In The Greek Healthcare System
Abstract
Authors
G Tritaki K Souliotis D Bouros I Papageorgiou A Diamantopoulos C Rinciog U Schmidt